DeepaRajanMD

Child Neurology • Bloomfield, PA

Epilepsy, Neurodevelopmental Disabilities

Director, Neurogenetics Program, UPMC Children’s Hospital of Pittsburgh

Join to view full profile

Dr. Rajan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rajan's full profile

Already have an account?

Office
4401 Penn Avenue
Bloomfield, PA 15224

Summary

Dr. Deepa Rajan is an Associate Professor in the Division of Neurology in the Department of Pediatrics, at Children's Hospital of Pittsburgh of UPMC and at the University Of Pittsburgh School Of Medicine.

Her recognitions include the Sanford N Cohen Award in 2010, The Bonita F Stanton Professionalism in Pediatrics Award 2010 and the Shelden Brenner Resident Research Award 2010.

She is currently the director of the Neurogenetics Program and Interim Director of the Program for Neurodevelopment in Rare Disorders
(NDRD). She lead multiple clinical trials in rare diseases and also has an active role in Medical Student and Child Neurology Fellow teaching in the Department of Pediatrics.

Education & Training

Bangalore Medical CollegeClass of 2006

Certifications & Licensure

PA State Medical License 2010 - 2024
MI State Medical License 2007 - 2010
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Epilepsy

Clinical Trials

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH Start of enrollment: 2016 Mar 01
Active, not recruiting
Phase 2, Phase 3
Roles: Principal Investigator, Contact
A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome Start of enrollment: 2020 Jul 16
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator
A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome Start of enrollment: 2019 Oct 23
Completed
Roles: Principal Investigator
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) Start of enrollment: 2022 Jul 21
Recruiting
Phase 2, Phase 3
Roles: Principal Investigator, Contact
Longitudinal Study of Neurodegenerative Disorders Start of enrollment: 2012 Jan 11
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Press Mentions

Protein Mutations Cause Rare Genetic Disease in ChildrenJune 1st, 2021
Mutations in GEMIN5 Protein Can Cause Rare Genetic Disorders in ChildrenMay 10th, 2021
Rare Genetic Disease Caused by Mutations in Protein That Controls RNA MetabolismMay 7th, 2021
Join now to see all